Diseases caused by phages

Bacteriophages in Health and Disease

Volumn , Issue , 2012, Pages 21-32

  Kuhl, Sarah ^a   Abedon, Stephen T ^b   Hyman, Paul ^c  

^a VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c ASHLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878320277     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (42)

1. Abedon, S.T. and LeJeune, J.T. (2005) Why bacteriophage encode exotoxins and other virulence factors. Evolutionary Bioinformatics Online 1, 97-110.
2. Balaban, N. and Rasooly, A. (2000) Staphylococcal enterotoxins. International Journal of Food Microbiology 61, 1-10.
3. Banks, D.J., Beres, S.B. and Musser, J.M. (2005) Contribution of phages to Group A Streptococcus genetic diversity and pathogenesis. In: Waldor M.K., Friedman D.I. and Adhya S.L. (eds) Phages: Their Role in Bacterial Pathogenesis and Biotechnology. ASM Press, Washington, DC, pp. 319-334.
4. Bisno, A.L. and Stevens, D.L. (2010) Streptococcus pyogenes. In: Mandell G.L., Bennett J.E. and Dolin R. (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Churchill Livingstone/Elsevier, Philadelphia, PA, pp. 2593-2610.
5. Bray, R. S. (1996) Armies of Pestilence: The Impact of Disease on History. James Clark & Co., Cambridge, UK.
6. Bukowski, M., Wladyka, B. and Dubin, G. (2010) Exfoliative toxins of Staphylococcus aureus. Toxins (Basel) 2, 1148-1165.
7. CDC (2006) Staphylococcal food poisoning. http://www.cdc.gov/ncidod/dbmd/diseaseinfo/staphylococcus_food_g.htm
8. CDC (2010) Cholera-prevention and control. http://www.cdc.gov/cholera/prevention.html
9. CDC (2011a) Diphtheria. http://www.cdc.gov/ncidod/dbmd/diseaseinfo/diptheria_t.htm
10. CDC (2011b) Infectious diseases related to travel-diphtheria http://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectiousdiseases-related-to-travel/diphtheria.htm
11. CDC (2011c) Scarlet fever: a group A streptococcal infection. http://www.cdc.gov/Features/ScarletFever/
12. Ciok, A.E. (2000) Horses and the diphtheria antitoxin. Academic Medicine 75, 396.
13. d'Hérelle, F. (1946) L'étude d'une Maladie, le Choléra: Maladie a Paradoxes. Rouge, Lausanne, Switzerland.
14. Diep, B.A. and Otto, M. (2008) The role of virulence determinants in community-associated MRSA pathogenesis. Trends in Microbiology 16, 361-369.
15. Faruque, S.M., Naser, I.B., Islam, M.J., Faruque, A.S.G., Ghosh, A.N., Nair, G.B., Sack, D.A. and Mekalanos, J.J. (2005) Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. Proceedings of the National Academy of Sciences USA 102, 1702-1707.
16. Freeman, V.J. (1951) Studies on the virulence of bacteriophage infected strains of Corynebacterium diphtheriae. Journal of Bacteriology 61, 675-688.
17. Gordon, R.J. and Lowy, F.D. (2008) Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clinical Infectious Diseases 46 Suppl 5, S350-S359.
18. Gupta, P., Singh, M.K., Singh, Y., Gautam, V., Kumar, S., Kumar, O. and Dhaked, R.K. (2011) Recombinant Shiga toxin B subunit elicits protection against Shiga toxin via mixed Th type immune response in mice. Vaccine 29, 8094-8100.
19. Hayashi, T., Baba, T., Matsumoto, H. and Terawaki, Y. (1990) Phage-conversion of cytotoxin production in Pseudomonas aeruginosa. Molecular Microbiology 4, 1703-1709.
20. Heydemann, J., Heydemann, J.S. and Antony, S. (2010) Acute infection of a total knee arthroplasty caused by Pasteurella multocida: a case report and a comprehensive review of the literature in the last 10 years. International Journal of Infectious Diseases 14 (Suppl. 3) e242-e245.
21. Hyman, P. and Abedon, S.T. (2008) Phage ecology of bacterial pathogenesis. In: Abedon S.T. (ed.) Bacteriophage Ecology. Cambridge University Press, Cambridge, UK, pp. 353-385.
22. Hynes, W.L., Hancock, L. and Ferretti, J.J. (1995) Analysis of a second bacteriophage hyaluronidase gene from Streptococcus pyogenes: evidence for a third hyaluronidase involved in extracellular enzymatic activity. Infection and Immunity 63, 3015-3020.
23. Kobayashi, S.D., Malachowa, N., Whitney, A.R., Braughton, K.R., Gardner, D.J., Long, D., Bubeck, W.J., Schneewind, O., Otto, M. and Deleo, F.R. (2011) Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. Journal of Infectious Diseases 204, 937-941.
24. Lopez, A.L., Clemens, J.D., Deen, J. and Jodar, L. (2008) Cholera vaccines for the developing world. Human Vaccines 4, 165-169.
25. Morison, J. (1932) Bacteriophage in the Treatment and Prevention of Cholera. H.K. Lewis, London, UK.
26. Mortimer, P.P. (2011) The diphtheria vaccine debacle of 1940 that ushered in comprehensive childhood immunization in the United Kingdom. Epidemiology and Infection 139, 487-493.
27. Novick, R.P., Christie, G.E. and Penades, J.R. (2010) The phage-related chromosomal islands of Gram-positive bacteria. Nature Reviews Microbiology 8, 541-551.
28. Pullinger, G.D., Bevir, T. and Lax, A.J. (2004) The Pasteurella multocida toxin is encoded within a lysogenic bacteriophage. Molecular Microbiology 51, 255-269.
29. Que, Y.A. and Moreillon, P. (2010) Staphylococcal aureus (including staphylococcal toxic shock). In: Mandell G.L., Bennett J.E. and Dolin R. (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Churchill Livingstone/Elsevier, Philadelphia, PA, pp. 2543-2578.
30. Rasko, D.A., Webster, D.R., Sahl, J.W., Bashir, A., Boisen, N., Scheutz, F., Paxinos, E.E., Sebra, R., Chin, C.S., Iliopoulos, D., Klammer, A., Peluso, P., Lee, L., Kislyuk, A.O., Bullard, J., Kasarskis, A., Wang, S., Eid, J., Rank, D., Redman, J.C., Steyert, S.R., Frimodt-Moller, J., Struve, C., Petersen, A.M., Krogfelt, K.A., Nataro, J.P., Schadt, E.E. and Waldor, M.K. (2011) Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. New England Journal of Medicine 365, 709-717.
31. Relman, D.A. (2011) Microbial genomics and infectious diseases. New England Journal of Medicine 365, 347-357.
32. Sherman, I. W. (2006) The Power of Plagues. ASM Press, Washington, DC.
33. Sobel, J. (2005) Botulism. Clinical Infectious Diseases 41, 1167-1173.
34. Stevens, D.L. (1995) Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerging Infectious Diseases 1, 69-78.
35. Stulberg, D.L., Penrod, M.A. and Blatny, R.A. (2002) Common bacterial skin infections. American Family Physician 66, 119-124.
36. Tao, X., Schiering, N., Zeng, H.Y., Ringe, D. and Murphy, J.R. (1994) Iron, DtxR, and the regulation of diphtheria toxin expression. Molecular Microbiology 14, 191-197.
37. Verkaik, N.J., Benard, M., Boelens, H.A., de Vogel, C.P., Nouwen, J.L., Verbrugh, H.A., Melles, D.C., van Belkum, A. and van Wamel, W.J. (2011) Immune evasion cluster-positive bacteriophages are highly prevalent among human Staphylococcus aureus strains, but they are not essential in the first stages of nasal colonization. Clinical Microbiology and Infection 17, 343-348.
38. Vitek, C.R., Brisgalov, S.P., Bragina, V.Y., Zhilyakov, A.M., Bisgard, K.M., Brennan, M., Kravtsova, O.N., Lushniak, B.D., Lyerla, R., Markina, S.S. and Strebel, P.M. (1999) Epidemiology of epidemic diphtheria in three regions, Russia, 1994-1996. European Journal of Epidemiology 15, 75-83.
39. Waldor, M.K. and Mekalanos, J.J. (1996) Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272, 1910-1914.
40. Wong, C.S., Jelacic, S., Habeeb, R.I., Watkins, S.L. and Tarr, P.I. (2000) The risk of the hemolyticuremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. New England Journal of Medicine 342, 1930-1936.
41. World Health Organization (2008) The Global Burden of Disease: (2004) Update. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf
42. Zurlo, J. J. (2010) Pasteurella species. In: Mandell G.L., Bennett J.E. and Dolin R. (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Churchill Livingstone/Elsevier, Philadelphia, PA, pp. 2939-2942.